Osteoblast role in osteoarthritis pathogenesis

Journal of Cellular Physiology

Volumn 232, Issue 11, 2017, Pages 2957-2963

  Maruotti, Nicola ^a   Corrado, Addolorata ^a   Cantatore, Francesco P ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

bone; osteoarthritis; osteoblast

Indexed keywords

BETA CATENIN; ENDOTHELIN 1; EPHRIN; GROWTH FACTOR; PROTEINASE; VASCULOTROPIN; WNT PROTEIN;

BONE METABOLISM; BONE REMODELING; CELL DIFFERENTIATION; CELL HYPOXIA; GENE EXPRESSION; HUMAN; OSTEOARTHRITIS; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; WNT SIGNALING PATHWAY; ANIMAL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; JOINT; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION;

ANIMALS; BONE REMODELING; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HUMANS; JOINTS; OSTEOARTHRITIS; OSTEOBLASTS; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 85026304384     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25969     Document Type: Review

References (79)

1. Abed, É, Chan, T. F., Delalandre, A., Martel-Pelletier, J., Pelletier, J. P., & Lajeunesse, D. (2011). R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblasts. Arthritis & Rheumatism, 63, 3865–3875.
2. Abed, É, Couchourel, D., Delalandre, A., Duval, N., Pelletier, J. P., Martel-Pelletier, J., & Lajeunesse, D. (2014). Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity. Bone, 59, 28–36.
3. Abed, É, Bouvard, B., Martineau, X., Jouzeau, J. Y., Reboul, P., & Lajeunesse, D. (2015). Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. Bone, 75, 111–119.
4. Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997). Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO Journal, 16, 3797–3804.
5. Bonewald, L. F., & Johnson, M. L. (2008). Osteocytes, mechanosensing and Wnt signaling. Bone, 42, 606–615.
6. Boskey, A. L. (1996). Matrix proteins and mineralization: An overview. Connective Tissue Research, 35, 357–363.
7. Boskey, A. L. (1998). Biomineralization: Conflicts, challenges, and opportunities. J Cell Biochem, Suppl 30-31, 83–91.
8. Bouvard, B., Abed, E., Yéléhé-Okouma, M., Bianchi, A., Mainard, D., Netter, P., … Reboul, P. (2014). Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther, 16, 459.
9. Cantatore, F. P., Corrado, A., Grano, M., Quarta, L., Colucci, S., & Melillo, N. (2004). Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation. Clinical Rheumatology, 23, 490–495.
10. Caplan, A. I. (1991). Mesenchymal stem cells. Journal of Orthopaedic Research, 9, 641–650.
11. Chan, T. F., Couchourel, D., Abed, E., Delalandre, A., Duval, N., & Lajeunesse, D. (2011). Elevated DKK-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. Journal of Bone and Mineral Research, 26, 1399–1410.
12. Chang, J., Jackson, S. G., Wardale, J., & Jones, S. W. (2014). Hypoxia modulates the phenotype of osteoblasts isolated from knee osteoarthritis patients, leading to undermineralized bone nodule formation. Arthritis Rheumatol, 66, 1789–1799.
13. Corrado, A., Cantatore, F. P., Grano, M., & Colucci, S. (2005). Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects. Clinical Rheumatology, 24, 527–534.
14. Corrado, A., Neve, A., & Cantatore, F. P. (2013). Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. Clinical and Experimental Medicine, 13, 81–84.
15. Couchourel, D., Aubry, I., Delalandre, A., Lavigne, M., Martel-Pelletier, J., Pelletier, J. P., & Lajeunesse, D. (2009). Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis & Rheumatism, 60, 1438–1450.
16. Dall'Ara, E., Ohman, C., Baleani, M., & Viceconti, M. (2011). Reduced tissue hardness of trabecular bone is associated with severe osteoarthritis. Journal of Biomechanics, 44, 1593–1598.
17. Davis, M. A., Ettinger, W. H., Neuhaus, J. M., & Hauck, W. W. (1988). Sex differences in osteoarthritis of the knee. The Role of Obesity. American Journal of Epidemiology, 127, 1019–1030.
18. Dequeker, J., Mohan, S., Finkelman, R. D., Aerssens, J., & Baylink, D. J. (1993). Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis & Rheumatism, 36, 1702–1708.
19. Dragojevič, J., Logar, D. B., Komadina, R., & Marc, J. (2011). Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue. Archives of Medical Research, 42, 392–397.
20. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997). Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell, 89, 747–754.
21. Dumond, H., Presle, N., Terlain, B., Mainard, D., Loeuille, D., Netter, P., & Pottie, P. (2003). Evidence for a key role of leptin in osteoarthritis. Arthritis & Rheumatism, 48, 3118–3129.
22. El Miedany, Y. M., Mehanna, A. N., & El Baddini, M. A. (2000). Altered bone mineral metabolism in patients with osteoarthritis. Joint Bone Spine, 67, 521–527.
23. Findlay, D. M., & Atkins, G. J. (2014). Osteoblast-chondrocyte interactions in osteoarthritis. Current Osteoporosis Reports, 12, 127–134.
24. Friedenstein, A. J., Chailakhyan, R. K., & Gerasimov, U. V. (1987). Bone marrow osteogenic stem cells: In vitro cultivation and transplantation in diffusion chambers. Cell and Tissue Kinetics, 20, 263–272.
25. Gevers, G., & Dequeker, J. (1987). Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis. Collagen and Related Research, 7, 435–442.
26. Glass, D. A., 2nd, Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., … Karsenty, G. (2005). Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell, 8, 751–764.
27. Hilal, G., Martel-Pelletier, J., Pelletier, J. P., Ranger, P., & Lajeunesse, D. (1998). Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: Possible role in subchondral bone sclerosis. Arthritis & Rheumatism, 41, 891–899.
28. Hilal, G., Massicotte, F., Martel-Pelletier, J., Fernandes, J. C., Pelletier, J. P., & Lajeunesse, D. (2001). Endogenous prostaglandin E2 and insulin like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. Journal of Bone and Mineral Research, 16, 713–721.
29. Hofbauer, L. C., & Schoppet, M. (2004). Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA, 292, 490–495.
30. Hopwood, B., Tsykin, A., Findlay, D. M., & Fazzalari, N. L. (2007). Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signaling. Arthritis Research & Therapy, 9, R100.
31. Junker, S., Frommer, K. W., Krumbholz, G., Tsiklauri, L., Gerstberger, R., Rehart, S., … Neumann, E. (2016). Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts. Matrix Biol. Pii: S0945-053X(16), 30195–30190. https://doi.org10.1016/j.matbio.2016.11.005. [Epub ahead of print].
32. Kim, H. H., Lee, D. E., Shin, J. N., Lee, Y. S., Jeon, Y. M., Chung, C. H., … Lee, Z. H. (1999). Receptor activator of NF-kB recruits multiple TRAF family adaptors and activates c-jun N-terminal kinase. FEBS Letters, 443, 297–302.
33. Kobayashi, N., Kadono, Y., Naito, A., Matsumoto, K., Yamamoto, T., Tanaka, S., & Inoue, J. (2001). Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO Journal, 20, 1271–1280.
34. Komori, T. (2003). Requisite roles of Runx2 and Cbfb in skeletal development. Journal of Bone Mineral Metabolism, 21, 193–197.
35. Komori, T. (2010). Regulation of bone development and extracellularmatrix protein genes by RUNX2. Cell and Tissue Research, 339, 189–195.
36. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., … Kishimoto, T. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755–764.
37. Kumarasinghe, D. D., Sullivan, T., Kuliwaba, J. S., Fazzalari, N. L., & Atkins, G. J. (2012). Evidence for the dysregulated expression of TWIST1, TGFβ1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients. Osteoarthritis and Cartilage, 20, 1357–1366.
38. Kwan Tat, S., Pelletier, J. P., Amiable, N., Boileau, C., Lajeunesse, D., Duval, N., & Martel-Pelletier, J. (2008). Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis & Rheumatism, 58, 3820–3830.
39. Kwan Tat, S., Pelletier, J. P., Lajeunesse, D., Fahmi, H., Lavigne, M., & Martel-Pelletier, J. (2008). The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clinical and Experimental Rheumatology, 26, 295–304.
40. Lajeunesse, D., & Reboul, P. (2003). Subchondral bone in osteoarthritis: A biologic link with articular cartilage leading to abnormal remodeling. Current Opinion in Rheumatology, 15, 628–633.
41. Li, B., & Aspden, R. M. (1997). Material properties of bone from the femoral neck and calcar femorale of patients with osteoporosis or osteoarthritis. Osteoporosis International, 7, 450–456.
42. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., … He, X. (2002). Control of bcatenin phosphorylation/degradation by a dual-kinase mechanism. Cell, 108, 837–847.
43. Logar, D. B., Komadina, R., Prezelj, J., Ostanek, B., Trost, Z., & Marc, J. (2007). Expression of bone resorption genes in osteoarthritis and in osteoporosis. Journal of Bone and Mineral Metabolism, 25, 219–225.
44. Mandelin, J., Hukkanen, M., Li, T. F., Korhonen, M., Liljeström, M., Sillat, T., … Konttinen, Y. T. (2006). Human osteoblasts produce cathepsin K. Bone, 38, 769–777.
45. Mansell, J. P., & Bailey, A. J. (1998). Abnormal cancellous bone collagen metabolism in osteoarthritis. The Journal of Clinical Investigation, 101, 1596–1603.
46. Mansell, J. P., Tarlton, J. F., & Bailey, A. J. (1997). Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. British Journal of Rheumatology, 36, 16–19.
47. Maruotti, N., Corrado, A., Neve, A., & Cantatore, F. P. (2012). Bisphosphonates: Effects on osteoblast. European Journal of Clinical Pharmacology, 68, 1013–1018.
48. Maruotti, N., Corrado, A., Neve, A., & Cantatore, F. P. (2013). Systemic effects of Wnt signaling. Journal of Cellular Physiology, 228, 1428–1432.
49. Massicotte, F., Aubry, I., Martel-Pelletier, J., Pelletier, J. P., Fernandes, J., & Lajeunesse, D. (2006). Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Research & Therapy, 8, R177.
50. Massicotte, F., Lajeunesse, D., Benderdour, M., Pelletier, J. P., Hilal, G., Duval, N., & Martel-Pelletier, J. (2002). Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients? Osteoarthritis and Cartilage, 10, 491–500.
51. Matsumoto, M., Sudo, T., Saito, T., Osada, H., & Tsujimoto, M. (2000). Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kB ligand (RANKL). The Journal of Biological Chemistry, 275, 31155–31161.
52. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991). t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proceedings of the National Academy of Sciences of the United States of America, 88, 10431–10434.
53. Monfort, J., Tardif, G., Roughley, P., Reboul, P., Boileau, C., Bishop, P. N., … Martel-Pelletier, J. (2008). Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: A novel target for MMP-13 in osteoarthritis. Osteoarthritis and Cartilage, 16, 749–755.
54. Moon, R. T., Bowerman, B., Boutros, M., & Perrimon, N. (2002). The promise and perils of Wnt signaling through b-catenin. Science, 296, 1644–1646.
55. Mutabaruka, M. S., Aoulad Aissa, M., Delalandre, A., Lavigne, M., & Lajeunesse, D. (2010). Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Research & Therapy 12, R20.
56. Neve, A., Corrado, A., & Cantatore, F. P. (2011). Osteoblast physiology in normal and pathological conditions. Cell and Tissue Research, 343, 289–302.
57. Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993). Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology, 194, 314–331.
58. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., … Owen, M. J. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 89, 765–771.
59. Owen, M. (1988). Marrow stromal stem cells. Journal of Cell Science. Supplement, 10, 63–76.
60. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., … Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143–147.
61. Prasadam, I., Crawford, R., & Xiao, Y. (2012). Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes—possible pathogenic role in osteoarthritis. Journal of Rheumatology, 39, 621–634.
62. Prasadam, I., Farnaghi, S., Feng, J. Q., Gu, W., Perry, S., Crawford, R., & Xiao, Y. (2013). Impact of extracellular matrix derived from osteoarthritis subchondral bone osteoblasts on osteocytes: Role of integrinβ1 and focal adhesion kinase signaling cues. Arthritis Research & Therapy, 15, R150.
63. Sakao, K., Takahashi, K. A., Mazda, O., Arai, Y., Tonomura, H., Inoue, A., … Kubo, T. (2008). Enhanced expression of interleukin-6, matrix metalloproteinase-13, and receptor activator of NF-kappaB ligand in cells derived from osteoarthritic subchondral bone. Journal of Orthopaedic Science, 13, 202–210.
64. Sakao, K., Takahashi, K. A., Arai, Y., Saito, M., Honjo, K., Hiraoka, N., … Kubo, T. (2009). Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis. Journal of Bone and Mineral Metabolism, 27, 412–423.
65. Sanchez, C., Deberg, M. A., Piccardi, N., Msika, P., Reginster, J. Y., & Henrotin, Y. E. (2005). Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis and Cartilage, 13, 979–987.
66. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Lüthy, R., … Boyle, W. J. (1997). Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 89, 309–319.
67. Sin, A., Tang, W., Wen, C. Y., Chung, S. K., & Chiu, K. Y. (2015). The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis. Osteoarthritis and Cartilage, 23, 516–524.
68. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., … He, X. (2000). LDL-receptor-related proteins in Wnt signal transduction. Nature, 407, 530–535.
69. Tat, S. K., Padrines, M., Theoleyre, S., Couillaud-Battaglia, S., Heymann, D., Redini, F., & Fortun, Y. (2006). OPG/membranous-RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation. Bone, 39, 706–715.
70. Tat, S. K., Pelletier, J. P., Lajeunesse, D., Fahmi, H., Duval, N., & Martel-Pelletier, J. (2008). Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: Influence of osteotropic factors. Bone, 43, 284–291.
71. Tornero-Esteban, P., Peralta-Sastre, A., Herranz, E., Rodríguez-Rodríguez, L., Mucientes, A., Abásolo, L., … Lamas, J. R. (2015). Altered expression of wnt signaling pathway components in osteogenesis of mesenchymal stem cells in osteoarthritis patients. PLoS ONE, 10:e0137170.
72. Valdes, A. M., & Spector, T. D. (2010). The genetic epidemiology of osteoarthritis. Current Opinion in Rheumatology, 22, 139–143.
73. Wehrli, M., Dougan, S. T., Caldwell, K., O'Keefe, L., Schwartz, S., Vaizel-Ohayon, D., … DiNardo, S. (2000). Arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature, 407, 527–530.
74. Westendorf, J. J., Kahler, R. A., & Schroeder, T. M. (2004). Wnt signaling in osteoblasts and bone diseases. Gen, 341, 19–39.
75. Willert, K., & Jones, K. A. (2006). Wnt signaling: Is the party in the nucleus? Genes & Development, 20, 1394–1404.
76. Wu, R., Wang, W., Huang, G., Mao, X., Chen, Y., Tang, Q., & Liao, L. (2016). Endothelin-1 induces oncostatin M expression in osteoarthritis osteoblasts by trans-activating the oncostatin M gene promoter via Ets-1. Molecular Medicine Reports, 13, 3559–3566.
77. Yamaguchi, A., Komori, T., & Suda, T. (2000). Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocrine Reviews, 21, 393–411.
78. Yu, X., & Malenka, R. C. (2003). Beta-catenin is critical for dendritic morphogenesis. Nature Neuroscience, 6, 1169–1177.
79. Zhen, G., Wen, C., Jia, X., Li, Y., Crane, JL., Mears, SC., … Cao, X. (2013). Inhibition of TGF-β signaling in mesenchymal stemcells of subchondral bone attenuates osteoarthritis. Nature Medicine, 19, 704–712.